IDTs San Diego, California, Manufacturing Facility Receives ISO 14001 Certification
Integrated DNA Technologies (IDT) has announced that its San Diego, California, manufacturing facility has attained ISO 14001:2004 certification for its environmental management systems. Now, both of IDT’s US manufacturing sites (Coralville, IA and San Diego, CA) have ISO 14001 certified environmental management systems. The Coralville facility was first certified in 2012 and recertified in 2014.
In honor of the San Diego facility’s achievement, the company is launching the IDT ISO 14001 Sustainability Award, Earth Day. The contest for the inaugural award is focused on biodiversity and is open to all academic researchers in Southern California. Future awards may focus on other regions and other areas of study. The award recipient will receive $14,001 worth of Oligo Credit from IDT. Submission deadline is 15 June 2015, and the winner will be announced during a special event hosted at IDT’s San Diego facility on 18 August 2015.
Dan Dernbach, General Manager of IDT’s West Coast Operations, said attaining certification was a team effort. “ISO 14001 certification solidifies our commitment to meet the highest standard of environmental accountability. We are proud of our employees’ dedication to reducing our energy consumption and water usage while increasing our recycling efforts and our use of recyclable materials. We have also reduced the use of solvents and minimized the creation of hazardous waste.”
Dr Joseph A. Walder, IDT founder and CEO, agrees: “This certification is an important milestone for our San Diego facility. The site has grown significantly since its opening in 2005. In 2014 alone, we achieved double digit growth in both production and revenue, and increased the number of staff 20%. Attaining ISO 14001 certification while also further developing our business demonstrates our commitment to both sound environmental sustainability and responsible economic growth.”
“What better way to acknowledge the San Diego facility’s ISO 14001 achievement than to advance local research efforts at discovery in biodiversity,” said Dr Mark Behlke, IDT’s Chief Scientific Officer. “With this award, we hope to encourage and support innovative solutions that make a difference in our local communities and for our planet.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance